Telormedix

PharmaceuticalsSeries BSwitzerlandtelormedix.com

Latest round

Series B

Last raised

Dec 2013

Total raised

$32M

Investors

5

About Telormedix

Founded in 2007 in Switzerland, Telormedix SA specializes in biotechnology solutions, primarily targeting cancer therapies. The headquarters is located in Switzerland, and there is no mention of subsidiaries or a parent company.Telormedix SA develops targeted therapeutics and diagnostics aimed at enhancing cancer treatment efficacy.While specific revenue figures are not provided, Telormedix SA operates under a business model that supports sustainable growth and investment in its product development pipeline.Telormedix SA's future growth strategy includes the development and launch of new cancer therapies designed to enter clinical trials in the upcoming years. Additionally, the exit of NextTech Invest indicates a strategic repositioning as the company seeks to attract new investment and partnerships to further its research initiatives.

Who invested in Telormedix

5 investors across 3 rounds

See all investors in Telormedix

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Dec 2, 2013

    Amount

    $6.8M

    Investors

    Locked

  2. Series B

    Jan 10, 2012

    Amount

    $7.9M

    Investors

    Locked

  3. Series A

    Sep 30, 2008

    Amount

    $18M

    Investors

    Locked

Questions about Telormedix

Who invested in Telormedix?

Telormedix has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Telormedix raised?

Telormedix has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Telormedix last raise money?

Telormedix's most recent round on record is a Series B, in Dec 2013.

What does Telormedix do?

Founded in 2007 in Switzerland, Telormedix SA specializes in biotechnology solutions, primarily targeting cancer therapies.

Where is Telormedix headquartered?

Telormedix is headquartered in Switzerland.

Which VCs invest in companies like Telormedix?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Telormedix's stage. Their profiles are linked below.

Raising like Telormedix? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.